{"SPADE_N_00112": {"Clinical Information": [], "Patent Information": [{"Patent No": "US 2023/0416797 A1", "Patent Link": "http://www.lens.org/lens/patent/US_2023_0416797_A1", "Patent Type": "Patent Application", "Publication Date": "2023-12-28", "Family Info": "JP2023548477A,EP4243844A1,CN116685204A,WO2022104321A1", "Patent Title": "MODULATING ANTIMICROBIAL PEPTIDE HALF-LIFE", "Abstract": "Methods of modulating the half-life of an antimicrobial peptide are described. The method may include administering an antimicrobial peptide to an environment where the antimicrobial peptide remains active until a specified endpoint, and on or after the specified endpoint, digesting the antimicrobial peptide with a protease to thereby inactivate the antimicrobial peptide and modulate its half-life. Compositions and kits for modulating the half-life of an antimicrobial peptide are also described."}, {"Patent No": "US 2023/0416797 A1", "Patent Link": "http://www.lens.org/lens/patent/US_2023_0416797_A1", "Patent Type": "Patent Application", "Publication Date": "2023-12-28", "Family Info": "JP2023548477A,EP4243844A1,CN116685204A,WO2022104321A1", "Patent Title": "MODULATING ANTIMICROBIAL PEPTIDE HALF-LIFE", "Abstract": "Methods of modulating the half-life of an antimicrobial peptide are described. The method may include administering an antimicrobial peptide to an environment where the antimicrobial peptide remains active until a specified endpoint, and on or after the specified endpoint, digesting the antimicrobial peptide with a protease to thereby inactivate the antimicrobial peptide and modulate its half-life. Compositions and kits for modulating the half-life of an antimicrobial peptide are also described."}], "Sequence Information": {"SPADE ID": "SPADE_N_00112", "Peptide Name": "Enterocin E-760 (Bacteriocin)", "Source": "Enterococcus sp. (Gram-positive bacteria)", "Family": "Belongs to the class IIb bacteriocin", "Gene": "Not found", "Sequence": "NRWYCNSAAGGVGGAAVCGLAGYVGEAKENIAGEVRKGWGMAGGFTHNKACKSFPGSGWASG", "Sequence Length": 62, "UniProt Entry": ["http://www.uniprot.org/uniprot/P85147"], "Protein Existence": "Protein level", "Biological Activity": ["Antimicrobial", "Antibacterial", "Anti-Gram+", "Anti-Gram-"], "Target Organism": "[Ref.18086839]Gram-positive bacteria:Listeria monocytogenes 9-72 (MIC=0.1 μg/ml), Staphylococcus epidermidis (MIC=1.6 μg/ml), S. aureus (MIC=1.6 μg/ml);Gram-negative bacteria:S. enterica serovar Enteritidis 1 (MIC=0.2 μg/ml), S. enterica serovar Enteritidis 4 (MIC=0.4 μg/ml), S. enterica serovar Enteritidis 204 (MIC=0.2 μg/ml), S. enterica serovar Enteritidis 237 (MIC=0.2 μg/ml), S. enterica serovar Choleraesuis 434/4 (MIC=0.4 μg/ml), S. enterica serovar Choleraesuis 370 (MIC=0.4 μg/ml), S. enterica serovar Typhimurium 383/60 (MIC=0.4 μg/ml), S. enterica serovar Typhimurium 320 (MIC=0.2 μg/ml), S. enterica serovar Gallinarum biovar Pullorum (MIC=0.4 μg/ml), Escherichia coli HB101 (MIC=0.1 μg/ml), E. coli C600 (MIC=0.1 μg/ml), E. coli O157:H7 Y-63 (MIC=1.6 μg/ml), E. coli O157:H7 G-3 (MIC=1.6 μg/ml), E. coli O157:H7 OD-3 (MIC=1.6 μg/ml), E. coli O157:H7 T-39 (MIC=1.6 μg/ml), Yersinia enterocolitica 03 (MIC=0.1 μg/ml), Y. enterocolitica 09 (MIC=0.1 μg/ml), Y. enterocolitica 04 (MIC=0.1 μg/ml), Y. pseudotuberculosis ser 4 (MIC=3.2 μg/ml), Y. pseudotuberculosis 14 (MIC=3.2 μg/ml), Citrobacter freundii (MIC=1.6 μg/ml), Klebsiella pneumoniae (MIC=3.2 μg/ml), Shigella dysenteriae (MIC=0.1 μg/ml), Campylobacter jejuni L4 (MIC=0.1 μg/ml), Campylobacter P 1-R (MIC=0.2 μg/ml), Campylobacter P-45 (MIC=0.4 μg/ml), Campylobacter lari R (MIC=0.2 μg/ml), Campylobacter LB 6-R (MIC=0.1 μg/ml), Campylobacter C/D (MIC=0.2 μg/ml),.", "Hemolytic Activity": "No hemolysis information or data found in the reference(s) presented in this entry", "Cytotoxicity": "No cytotoxicity information found in the reference(s) presented", "Binding Target": "Not found", "Linear/Cyclic": "Linear", "N-terminal Modification": "Free", "C-terminal Modification": "Free", "Stereochemistry": "L", "Structure Description": "Not found", "Formula": "C269H403N81O80S4", "Mass": 6179.83, "PI": 8.99, "Net Charge": 4, "Hydrophobicity": -0.18, "Half Life": "Mammalian:1.4 hourYeast:3 minE.coli:>10 hour", "Function": "The enterocin demonstrated thermostability by retaining activity after 5 min at 100 degrees C and was stable at pH values between 5.0 and 8.7. However, activity was lost below pH 3.0 and above pH 9.5. No hemolytic activity.", "Literature": [{"Title": "Isolation and purification of enterocin E-760 with broad antimicrobial activity against gram-positive and Gram-negative bacteria.", "Pubmed ID": "18086839", "Reference": "Antimicrob Agents Chemother. 2008 Mar;52(3)1094-1100.", "Author": "Line JE, Svetoch EA, Eruslanov BV, Perelygin VV, Mitsevich EV, Mitsevich IP, Levchuk VP, Svetoch OE, Seal BS, Siragusa GR, Stern NJ.", "URL": "http://www.ncbi.nlm.nih.gov/pubmed/?term=18086839"}], "Frequent Amino Acids": "GAK", "Absent Amino Acids": "DOQU", "Basic Residues": 7, "Acidic Residues": 3, "Hydrophobic Residues": 25, "Polar Residues": 35, "Positive Residues": 7, "Negative Residues": 3, "Similar Sequences": [{"SPADE_ID": "SPADE_N_00177", "Similarity": 0.967741935483871, "Sequence": "NRWYCNSAAGGVGGAAGCVLAGYVGEAKENIAGEVRKGWGMAGGFTHNKACKSFPGSGWASG"}, {"SPADE_ID": "SPADE_N_00117", "Similarity": 0.5555555555555556, "Sequence": "NRWTNAYSAALGCAVPGVKYGKKLGGVWGAVIGGVGGAAVCGLAGYVRKG"}, {"SPADE_ID": "SPADE_N_06090", "Similarity": 0.5555555555555556, "Sequence": "MKQLNSEQLQNIIGGNRWTNAYSAALGCAVPGVKYGKKLGGVWGAVIGGVGGAAVCGLAGYVRKG"}]}}}